Eledon Pharmaceuticals (STU:2TK) Cyclically Adjusted Book per Share: €25.92 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:2TK Eledon Pharmaceuticals Inc STU:2TK
26 GF Score
Price €2.88
! 1 Warning Sign
View Full Analysis

What is Eledon Pharmaceuticals Cyclically Adjusted Book per Share?

Eledon Pharmaceuticals STU:2TK -2.04% 26 Cyclically Adjusted Book per Share is €25.92 as of Jun. 2026. GuruFocus rates STU:2TK with a GF Score™ of 26/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Eledon Pharmaceuticals's adjusted book value per share for the three months ended in Jun. 2026 was €0.354. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €25.92 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Eledon Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was -58.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-22), Eledon Pharmaceuticals's current stock price is €2.88. Eledon Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €25.92. Eledon Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 0.11.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eledon Pharmaceuticals was 0.11. The lowest was 0.00. And the median was 0.00.


Eledon Pharmaceuticals  (STU:2TK) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Eledon Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2.88/25.92
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eledon Pharmaceuticals was 0.11. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Eledon Pharmaceuticals Cyclically Adjusted Book per Share Related Terms


Eledon Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Eledon Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eledon Pharmaceuticals Cyclically Adjusted Book per Share Chart

Eledon Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 123.34 44.01

Eledon Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.18 54.91 44.01 29.92 25.92

STU:2TK vs NMRA, ALXO, IMRX: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Eledon Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eledon Pharmaceuticals Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eledon Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Eledon Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


STU:2TK
26GF Score
Eledon Pharmaceuticals Inc STU:2TK
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eledon Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eledon Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.354/333.9520*333.9520
=0.354

Current CPI (Jun. 2026) = 333.9520.

Eledon Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201609 192.564 241.428 266.362
201612 -20.393 241.432 -28.208
201703 156.036 243.801 213.734
201706 54.044 244.955 73.679
201709 44.816 246.819 60.637
201712 41.613 246.524 56.371
201803 37.679 249.554 50.422
201806 35.210 251.989 46.663
201809 30.029 252.439 39.725
201812 24.356 251.233 32.375
201903 16.737 254.202 21.988
201906 19.678 256.143 25.656
201909 16.832 256.759 21.892
201912 11.832 256.974 15.376
202003 11.903 258.115 15.400
202006 7.714 257.797 9.993
202009 14.321 260.280 18.375
202012 10.334 260.474 13.249
202103 10.796 264.877 13.611
202106 10.357 271.696 12.730
202109 10.144 274.310 12.350
202112 10.144 278.802 12.151
202203 10.317 287.504 11.984
202206 10.272 296.311 11.577
202209 10.359 296.808 11.655
202212 5.768 296.797 6.490
202303 5.070 301.836 5.609
202306 4.003 305.109 4.381
202309 3.635 307.789 3.944
202312 -1.836 306.746 -1.999
202403 2.774 312.332 2.966
202406 -0.205 314.175 -0.218
202409 1.664 315.301 1.762
202412 0.997 315.605 1.055
202503 1.770 319.799 1.848
202506 0.729 322.561 0.755
202509 0.503 324.800 0.517
202512 0.918 324.054 0.946
202603 0.510 330.213 0.516
202606 0.354 333.952 0.354

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €25.92 mean?
Eledon Pharmaceuticals (STU:2TK) has a Cyclically Adjusted Book per Share of €25.92 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Eledon Pharmaceuticals and its competitors.
Is Eledon Pharmaceuticals' Cyclically Adjusted Book per Share too high?
Eledon Pharmaceuticals' current Cyclically Adjusted Book per Share is €25.92. Overall, Eledon Pharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Eledon Pharmaceuticals' Cyclically Adjusted Book per Share compare to NMRA and ALXO?
Eledon Pharmaceuticals' Cyclically Adjusted Book per Share of €25.92 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Eledon Pharmaceuticals and its competitors. Eledon Pharmaceuticals's current Cyclically Adjusted Book per Share is €25.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eledon Pharmaceuticals stock overvalued right now?
Eledon Pharmaceuticals (STU:2TK) has a current Cyclically Adjusted Book per Share of €25.92. The current Cyclically Adjusted Book per Share is €25.92. Eledon Pharmaceuticals' overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Eledon Pharmaceuticals (STU:2TK), the current Cyclically Adjusted Book per Share is €25.92 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eledon Pharmaceuticals Business Description

Other Exchanges ELDN:USA
Address 19800 MacArthur Boulevard, Suite 250, Irvine, CA, USA, 92612
Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.
26GF Score

Get the complete analysis for STU:2TK

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.88
Price